Sethuraman Natarajan's Form 4 filing
Entrada Therapeutics, Inc. (TRDA) · filed Sep 10, 2024
- Accession no.
- 0001689375-24-000053
- Filed
- Sep 10, 2024
- Trade date
- Sep 6-9, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $49.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sethuraman NatarajanCIK 0001873394 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | Common Stock | SSaleDisposed | −600 | $15.24 | −$9,144 | 186,458 | Direct | |
| Sep 9, 2024 | Common Stock | SSaleDisposed | −2,642 | $15.09 | −$39,867.78 | 183,816 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.